GlaxoSmithkline Biologicals SA v.Human Biolife India Pvt. Ltd. & Ors
Delhi High Court - Orders · CS(COMM) 948/2023
GlaxoSmithkline Biologicals SA sued Human Biolife India Pvt. Ltd. for trademark infringement concerning its well-known vaccine brands including ENGERIX, HAVRIX, INFANRIX, ROTARIX, CERVARIX, and SYNFLORIX. The defendant had adopted confusingly similar marks such as RUTORIX, DROTARIX, AMIRIX, CEFTARIX, and MIRIX for pharmaceutical products. The parties entered into a settlement agreement dated 24.04.2026, and the Delhi High Court decreed the suit in terms of the settlement, directing the defendant to cease all infringing use, recall products, cancel its trademark applications, and take down online listings.